Publication: Two Multiple Sclerosis Cases Developed Herpes Zoster During Use of Fingolimod
| dc.authorscopusid | 23062131200 | |
| dc.authorscopusid | 8944423400 | |
| dc.authorscopusid | 56042671700 | |
| dc.authorscopusid | 57189598520 | |
| dc.authorscopusid | 58505968100 | |
| dc.contributor.author | Terzi, M. | |
| dc.contributor.author | Duman, T. | |
| dc.contributor.author | Sen, S. | |
| dc.contributor.author | Güntel, M. | |
| dc.contributor.author | Şen, N.Ö. | |
| dc.date.accessioned | 2025-12-11T00:07:36Z | |
| dc.date.issued | 2018 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Terzi] Murat, Department of Neurology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Duman] Taskin, Department of Neurology, Mustafa Kemal Üniversitesi, Antakya, Turkey; [Sen] Sedat, Department of Neurology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Güntel] Murat, Department of Neurology, Mustafa Kemal Üniversitesi, Antakya, Turkey; [Şen] Nalan Örtücü, Dermatology Clinic, Gazi State Hospital, Samsun, Samsun, Turkey | en_US |
| dc.description.abstract | Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system. Immunosuppressive and immunomodulating drugs are used during disease monitoring. Fingolimod is one of the immunomodulatory treatments used in MS patients. It is a therapeutic agent acting on lymphocytes. Latent varicella-zoster virus infections may occur in MS patients receiving fingolimod therapy. In this article, the information of two cases with varicella-zoster virus reactivation during fingolimod use were presented. © 2018 OMU | en_US |
| dc.identifier.doi | 10.5835/jecm.omu.35.01.006 | |
| dc.identifier.endpage | 30 | en_US |
| dc.identifier.issn | 1309-4483 | |
| dc.identifier.issn | 1309-5129 | |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.scopus | 2-s2.0-85105278426 | |
| dc.identifier.scopusquality | Q4 | |
| dc.identifier.startpage | 27 | en_US |
| dc.identifier.uri | https://doi.org/10.5835/jecm.omu.35.01.006 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/36128 | |
| dc.identifier.volume | 35 | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Ondokuz Mayis Üniversitesi | en_US |
| dc.relation.ispartof | Journal of Experimental and Clinical Medicine (Turkey) | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Fingolimod | en_US |
| dc.subject | Multiple Sclerosis | en_US |
| dc.subject | Varicella-Zoster Virus Reactivation | en_US |
| dc.subject | Zoster | en_US |
| dc.title | Two Multiple Sclerosis Cases Developed Herpes Zoster During Use of Fingolimod | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |